focus
It’s that time of the year again when I recognize the Best Biopharma CEO of the year.
This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.
advertisement
What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
Canadians with cystic fibrosis outlive Americans by a decade
Next article： How one medical school became remarkably diverse
Next article： How one medical school became remarkably diverse
